CORMEDIX
CorMedix Inc. is a specialty pharmaceutical company that develops and seeks to commercialize products for the treatment of cardiac, renal and infectious diseases. Specifically, our goal is to treat human disease by reducing commonly associated renal, cardiovascular, metabolic and infectious complications. Our therapeutic candidates may be small molecules, biologics, chemical entities, devices and/or diagnostics (molecular/lab tests) that enable targeted therapy in these areas. CorMedix has re... ceived CE Mark approval for Neutrolin®, a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients. Our goal is to provide risk mitigation solutions for central venous catheters (CVCs) in a variety of important indications.
CORMEDIX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.cormedix.com
Total Employee:
11+
Status:
Active
Contact:
908-517-9500
Email Addresses:
[email protected]
Total Funding:
11.47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.cormedix.com Semrush global rank: 3.49 M Semrush visits lastest month: 4.29 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CorMedix"
CorMedix - Crunchbase Company Profile & Funding
CorMedix Inc. is a specialty pharmaceutical company that develops and seeks to commercialize products for the treatment of cardiac, renal and infectious diseases. Specifically, our goal is to treat human disease by reducing …See details»
Management Team - CorMedix | Prevention of cardiac, renal and ...
Prior to joining CorMedix, Erin was Vice President of Market Access at Intarcia Therapeutics responsible for pricing, coverage, access, Real world evidence (RWE) and channel strategy …See details»
The Facts About CRBSIs | CorMedix Inc.
Scroll down for helpful resources and to connect with a CorMedix representative. CRBSI Fact Sheet. Get the facts about CRBSIs and how they affect HD-CVC patients . VIEW AND DOWNLOAD PDF. CRBSI Risks & Financial Impact. …See details»
Cormedix Inc. - LinkedIn
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases.See details»
CorMedix Inc. Announces Leadership Updates and Operational
May 12, 2022 Joe Todisco, Chief Executive Officer of CorMedix, officially joined the organization on Tuesday May 10 th. ...See details»
CorMedix Inc. Announces Leadership Updates and Operational …
May 12, 2022 Joe Todisco, Chief Executive Officer of CorMedix, officially joined the organization on Tuesday May 10 th.. Liz Hurlburt, EVP of Clinical Operations, has been promoted to an …See details»
CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial ...
Mar 30, 2023 CorMedix was informed by its primary contract manufacturing organization (“CMO”) that all corrective actions stemming from the FDA’s June 2022 inspection have been …See details»
Prevention of cardiac, renal and infectious diseases - CorMedix
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. …See details»
CORMEDIX INC. ANNOUNCES REGULATORY AND …
March 2, 2023. Berkeley Heights, NJ – March 2, 2023 – CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products …See details»
CorMedix Inc. Announces Regulatory and Manufacturing
Aug 8, 2022 BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...See details»
CorMedix Inc. Announces Regulatory and Manufacturing Updates
Mar 2, 2023 CorMedix, Inc. BERKELEY HEIGHTS, N.J., March 02, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and …See details»
CorMedix Inc. Announces Partnership With The Leapfrog Group
Dec 4, 2023 About CorMedix. CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life …See details»
CorMedix Inc. Reports First Quarter 2024 Financial Results and …
May 9, 2024 For the first quarter of 2024, CorMedix recorded a net loss of $14.5 million, or $0.25 per share, compared with a net loss of $10.6 million, or $0.24 per share, in the first quarter of …See details»
DefenCath Taurolidine and Heparin CLS | Official Website for HCPs
References: 1. DefenCath ® (taurolidine and heparin) catheter lock solution Prescribing Information, CorMedix, Berkeley Heights, New Jersey. 2. Agarwal AK, Roy-Chaudhury P, …See details»
CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR …
Mar 30, 2023 Conference Call Scheduled for Today at 8:30 a.m. Eastern Time Berkeley Heights, NJ – March 30, 2023 – CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company …See details»
CorMedix Inc. (CRMD) Stock Price, Quote & News - Stock Analysis
Nov 22, 2024 CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and …See details»
CorMedix Inc. Supports CMS Policy Updates Regarding Access to ...
6 days ago BERKELEY HEIGHTS, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing …See details»
CorMedix (CRMD) Earnings Date and Reports 2025 - MarketBeat
3 days ago CorMedix announced Q3 2024 earnings on October 30, 2024, reporting an EPS of -$0.05, which topped analysts' consensus estimates of -$0.10 by $0.05. Quarterly revenue was …See details»
Healthcare Professionals - CorMedix | Prevention of cardiac, renal …
At CorMedix, we are committed to partnering with healthcare professionals who are dedicated to improving human health and quality of life for patients. As part of that commitment, we …See details»
CorMedix Inc. Announces Partnership With The Leapfrog Group
Dec 4, 2023 – CorMedix to advocate for patient safety and infection prevention as part of Leapfrog’s Partners Advisory Committee BERKELEY HEIGHTS, N.J., Dec. 04, 2023 (GLOBE …See details»